For the next decade and beyond, the life science and healthcare sectors will be dominated by a number of factors. These include increasing regulation, shrinking drug portfolios, dwindling pipelines, ageing populations, globalisation, advancing technology, spiralling costs and a worldwide need to increase access to healthcare services.
Few industries experience change as rapidly as those in the life science and health care markets. Historically, the human capital requirements in this sector have been complex. Market forces are now accelerating the pace of change.
The businesses that prosper will be those that continue to attract, acquire, retain and develop the right leaders. In this climate, the need to look outside the healthcare sector for key people will only increase.
Our experience breeds your success
For more than 50 years, Mercuri Urval has built and maintained strong relationships with market leaders in core segments of this sector:
- Pharmaceuticals
- Biotechnology
- Generics
- Medical devices
- Diagnostics
- Consumer
- Private healthcare services
- Public healthcare services.
Around the world, our teams of highly experienced life sciences & healthcare consultants deliver a comprehensive range of human capital consulting solutions to this industry.